[Multiple sclerosis after treatment with anti-TNF-alpha antibodies].
Munteis-Olivas
Elvira
E
Pérez-García
Carolina
C
Roquer-González
Jaume
J
Maymo-Guarch
Joan
J
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab